Health

Show collection items

FDA approves first of new type of generic drugs

Swiss drugmaker Novartis' logo is seen behind scaffolding at the company's plant in the northern Swiss town of Stein, shown in January. The company's "biosimilar" drug Zarxio has received FDA approval. 

These "biosimilar" drugs closely mimic existing drugs but are made from living cells, blood components and tissue. In some cases, they could cut drugs costs.